Andrew Hykes, President and CEO at Inari Medical, Inc. (NARI), sold 72,757 shares at $65.31 ($4.8M) on 2023-08-16, disclosed to the SEC on 2023-08-18.
Open-market sale of $4.8M NARI by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.31 | 18,166 | $1.2M | 24.7% |
| 2 | $65.31 | 18,166 | $1.2M | 24.7% |
| 3 | $66.32 | 8,009 | $531K | 11.0% |
| 4 | $66.32 | 8,009 | $531K | 11.0% |
| 5 | $67.31 | 9,906 | $667K | 13.9% |
| 6 | $67.31 | 9,906 |
| $667K |
| 13.9% |
| 7 | $68.03 | 595 | $40K | 0.8% |
| Total | $66.10 avg | 72,757 | $4.8M | 100% |
| Filing → |
| NARI | SELL | 2024-10-31 | $150K | — | Filing → |
| NARI | SELL | 2024-08-22 | $150K | — | Filing → |
| NARI | SELL | 2024-07-24 | $166K | — | Filing → |